These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND LDH AND Diagnosis
310 results:

  • 1. Exploring the Prevalence and Prognostic Impact of Wilms Tumor 1 Exon 7 Mutation Status with Combinations of FLT3-ITD and NPM1 Mutations as Potential Molecular Biomarkers in Acute Myeloid leukemia Patients with Normal Cytogenetics.
    John Anitha GR; Radhakrishnan Chandraprabha V; Padmakumar D; Mohanan Sreelatha M; Padmakumar A; Gopinath P; Thampirajan Vimala Devi AR; Lathika Surendran S; Narayanan G; Sreedharan H; Mohanan Nair JKK
    Asian Pac J Cancer Prev; 2024 Oct; 25(10):3463-3470. PubMed ID: 39471012
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Musculoskeletal Symptoms and Misdiagnoses in Children With Acute Myeloid Leukaemia: A Nationwide Cohort Study.
    Jensen ABH; Andersen HRP; Jensen ST; Jensen CF; Amstrup J; Mathiasen R; Henriksen KA; Hasle H; Callesen MT; Brix N
    Eur J Haematol; 2025 Jan; 114(1):57-69. PubMed ID: 39295289
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inflammatory low back pain-associated malignancies mimicking spondylarthritis.
    Albayrak F; Kısacık B; Gündüz İ; Kudaş Ö; Koç E; Zengin O; Kutlu ND; Gür M; Küçük A; Şen MG; Ertaş ŞK; Akar ZA; Koca SS; Pehlivan Y
    Clin Rheumatol; 2024 Nov; 43(11):3345-3350. PubMed ID: 39285007
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Aberrant Expression of Small Nucleolar RNA
    Liu YQ; Chen SP; Yin Y; Shen JZ; Zeng MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):979-986. PubMed ID: 39192386
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group.
    Katodritou E; Dalampira D; Delimpasi S; Ntanasis-Stathopoulos I; Karaolidou F; Gkioka AI; Labropoulou V; Spanoudakis E; Triantafyllou T; Kotsopoulou M; Michalis E; Vadikolia C; Papadopoulou T; Sevastoudi A; Michael M; Daiou A; Pentidou A; Kostopoulos I; Palaska V; Gavriatopoulou M; Kyrtsonis MC; Verrou E; Kastritis E; Dimopoulos MA; Terpos E
    Am J Hematol; 2024 Oct; 99(10):1897-1905. PubMed ID: 38953456
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
    Lübke J; Schmid A; Christen D; Oude Elberink HNG; Span LFR; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Stefan A; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Brockow K; Zink A; Breynaert C; Leven T; Yavuz AS; Doubek M; Sabato V; Schug T; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Schwaab J
    Blood Adv; 2024 Jun; 8(11):2890-2900. PubMed ID: 38593217
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
    Aguirre LE; Jain A; Ball S; Ali NA; Volpe VO; Tinsley-Vance S; Sallman D; Sweet K; Lancet J; Padron E; Yun S; Kuykendall A; Komrokji R
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):459-467. PubMed ID: 38548563
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.
    Çağlayan Ş; Koç BŞ; Baba Ö; Bağlan E; Kurucu B; Yıldırım DG; Ayhan AC; Çakan M; Yener GO; Öztürk K; Çakmak F; Sönmez HE; Ayaz NA; Kısaarslan AP; Bakkaloğlu S; Kalyoncu M; Kılıç SÇ; Sözeri B
    Turk J Pediatr; 2024; 66(1):81-89. PubMed ID: 38523382
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
    Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
    Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia].
    Dou XL; Liu RX; Liu Y; Peng N; Wen L; Wu Y; Li Q; Zhong YP; Zhou X; Liao AJ; Jiang HN; Ma XJ; Dong HH; Fan SJ; Zhao YQ; Hu DH; Lu J
    Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):499-506. PubMed ID: 38317361
    [No Abstract]    [Full Text] [Related]  

  • 11. Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
    Didi I; Alliot JM; Dumas PY; Vergez F; Tavitian S; Largeaud L; Bidet A; Rieu JB; Luquet I; Lechevalier N; Delabesse E; Sarry A; De Grande AC; Bérard E; Pigneux A; Récher C; Simoncini D; Bertoli S
    Leuk Res; 2024 Jan; 136():107437. PubMed ID: 38215555
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tumor Lysis Syndrome Is Associated with Worse Outcomes in Adult Patients with Acute Lymphoblastic leukemia.
    Rios-Olais FA; Gil-Lopez F; Mora-Cañas A; Demichelis-Gómez R
    Acta Haematol; 2024; 147(4):391-401. PubMed ID: 37963436
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
    Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
    Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
    Fattizzo B; Gurnari C; Cassanello G; Bortolotti M; Awada H; Giammarco S; Consonni D; Sica S; Gandhi S; Trikha R; Large J; Salter S; Maciejewski JP; Barcellini W; Kulasekararaj AG
    Leukemia; 2023 Dec; 37(12):2479-2485. PubMed ID: 37794100
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic leukemia Patients.
    Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic leukemia.
    Aref S; El Tantawy A; Gouda E; Ayed M
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
    Yan X; Qin TJ; Li B; Qu SQ; Pan LJ; Li FH; Liu NN; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):276-283. PubMed ID: 37356995
    [No Abstract]    [Full Text] [Related]  

  • 18. Chromosomal aberrations and prognostic analysis of secondary acute myeloid leukemia-a retrospective study.
    Song M; Zhang T; Yang D; Xiao H; Wang H; Ye Q; Zhai Z
    PeerJ; 2023; 11():e15333. PubMed ID: 37214104
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinical Characteristics and Survival Analysis of Patients with Chronic Myelomonocytic leukemia].
    Wang JY; Chen JF; Wang SF; Guo QH; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):476-482. PubMed ID: 37096522
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression pattern of
    Chu X; Wu D; Zhang C; Hu S
    Scand J Clin Lab Invest; 2023 Jul; 83(4):207-211. PubMed ID: 37093849
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 16.